Invention Grant
- Patent Title: Drug effective for lymphogenous drug administrating method
-
Application No.: US16339545Application Date: 2017-08-31
-
Publication No.: US11559526B2Publication Date: 2023-01-24
- Inventor: Tetsuya Kodama , Shiro Mori , Go Nohara
- Applicant: TOHOKU UNIVERSITY , KABUSHIKI KAISHA YAKULT HONSHA
- Applicant Address: JP Sendai; JP Minato-ku
- Assignee: TOHOKU UNIVERSITY,KABUSHIKI KAISHA YAKULT HONSHA
- Current Assignee: TOHOKU UNIVERSITY,KABUSHIKI KAISHA YAKULT HONSHA
- Current Assignee Address: JP Sendai; JP Minato-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JPJP2016-197614 20161005
- International Application: PCT/JP2017/031483 WO 20170831
- International Announcement: WO2018/066278 WO 20180412
- Main IPC: A61K31/513
- IPC: A61K31/513 ; A61P35/00 ; A61K31/4745 ; A61K45/00 ; A61K31/337
Abstract:
Provided is a pharmaceutical composition suitable for administration of anticancer drugs into lymph nodes by means of lymphatic drug delivery systems. A pharmaceutical composition for therapeutic or prophylactic treatment of cancer to be administered into lymph nodes, comprising at least one anticancer drug selected from the group consisting of antimetabolites and anticancer plant alkaloids as an active ingredient.
Public/Granted literature
- US20200038400A1 DRUG EFFECTIVE FOR LYMPHOGENOUS DRUG ADMINISTRATING METHOD Public/Granted day:2020-02-06
Information query
IPC分类:
